Influenza viruses have an enormous impact in the U.S., with an estimated 25 million illnesses and 18,000 deaths in the 2022-23 flu season alone. However, the majority of virus particles are not infectious or are only...
For the first time in the world a team of researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against a type of bacteria that...
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the...
Recent research from CU Boulder may have finally revealed why humans tend to get sick from airborne viral diseases more often in drier environments. Published in December in PNAS-Nexus, the study found that airborne...
In a recent report published in Vaccine, researchers presented the coronavirus vaccines research and development roadmap (CVR) to promote the development of broadly protective coronavirus disease 2019 (COVID-19)...
The WHO recommends that healthcare systems worldwide implement single-dose vaccine programs to help eliminate cervical cancer. On December 20, 2022, the World Health Organization (WHO) updated its recommendations for...
From COVID to Lyme disease to various fungal afflictions, climate change has already worsened over 200 infectious diseases. Heat waves, floods, droughts, and rising temperatures fueled by climate change have made the...
Roughly six decades after the first attempt to develop a vaccine for respiratory syncytial virus, the Food and Drug Administration is poised to approve several shots by next winter. No RSV vaccine has ever been approved...
The original vaccinations for COVID-19 induce potent antibodies that protect against SARS-CoV-2. But a new Northwestern Medicine study shows the antibodies generated by those prior vaccinations or infections can...
Researchers in Japan have uncovered the mechanism for how the measles virus (MeV) can cause subacute sclerosing panencephalitis, or SSPE, a rare but fatal neurological disorder that can occur several years after a...